Literature DB >> 29883627

Comparative pathogenesis of enteric clostridial infections in humans and animals.

Francisco A Uzal1, Mauricio A Navarro2, Jihong Li3, John C Freedman3, Archana Shrestha3, Bruce A McClane3.   

Abstract

Several enteric clostridial diseases can affect humans and animals. Of these, the enteric infections caused by Clostridium perfringens and Clostridium difficile are amongst the most prevalent and they are reviewed here. C. perfringens type A strains encoding alpha toxin (CPA) are frequently associated with enteric disease of many animal mammalian species, but their role in these diseased mammals remains to be clarified. C. perfringens type B encoding CPA, beta (CPB) and epsilon (ETX) toxins causes necro-hemorrhagic enteritis, mostly in sheep, and these strains have been recently suggested to be involved in multiple sclerosis in humans, although evidence of this involvement is lacking. C. perfringens type C strains encode CPA and CPB and cause necrotizing enteritis in humans and animals, while CPA and ETX producing type D strains of C. perfringens produce enterotoxemia in sheep, goats and cattle, but are not known to cause spontaneous disease in humans. The role of C. perfringens type E in animal or human disease remains poorly defined. The newly revised toxinotype F encodes CPA and enterotoxin (CPE), the latter being responsible for food poisoning in humans, and the less prevalent antibiotic associated and sporadic diarrhea. The role of these strains in animal disease has not been fully described and remains controversial. Another newly created toxinotype, G, encodes CPA and necrotic enteritis toxin B-like (NetB), and is responsible for avian necrotic enteritis, but has not been associated with human disease. C. difficile produces colitis and/or enterocolitis in humans and multiple animal species. The main virulence factors of this microorganism are toxins A, B and an ADP-ribosyltransferase (CDT). Other clostridia causing enteric diseases in humans and/or animals are Clostridium spiroforme, Clostridium piliforme, Clostridium colinum, Clostridium sordellii, Clostridium chauvoei, Clostridium septicum, Clostridium botulinum, Clostridium butyricum and Clostridium neonatale. The zoonotic transmission of some, but not all these clostridsial species, has been demonstrated.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animals; Clostridial; Clostridium spp.; Humans; Pathogenesis

Mesh:

Year:  2018        PMID: 29883627      PMCID: PMC6281819          DOI: 10.1016/j.anaerobe.2018.06.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  113 in total

1.  Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers.

Authors:  L Petit; E Maier; M Gibert; M R Popoff; R Benz
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

2.  Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells.

Authors:  U Singh; L L Mitic; E U Wieckowski; J M Anderson; B A McClane
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

3.  Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers.

Authors:  O Shatursky; R Bayles; M Rogers; B H Jost; J G Songer; R K Tweten
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin.

Authors:  U Singh; C M Van Itallie; L L Mitic; J M Anderson; B A McClane
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

5.  Enteritis necroticans (pigbel) in a diabetic child.

Authors:  T M Petrillo; C M Beck-Sagué; J G Songer; C Abramowsky; J D Fortenberry; L Meacham; A G Dean; H Lee; D M Bueschel; S R Nesheim
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

Review 6.  [Necrotizing enterocolitis: a historical and current review].

Authors:  B Kreft; K Dalhoff; K Sack
Journal:  Med Klin (Munich)       Date:  2000-08-15

7.  Effects of intravenous injection of Clostridium perfringens type D epsilon toxin in calves.

Authors:  F A Uzal; W R Kelly; W E Morris; R A Assis
Journal:  J Comp Pathol       Date:  2002-01       Impact factor: 1.311

8.  Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.

Authors:  K Fujita; J Katahira; Y Horiguchi; N Sonoda; M Furuse; S Tsukita
Journal:  FEBS Lett       Date:  2000-07-07       Impact factor: 4.124

9.  Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops.

Authors:  M R Sarker; R J Carman; B A McClane
Journal:  Mol Microbiol       Date:  1999-09       Impact factor: 3.501

10.  Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin.

Authors:  J W Finnie; P C Blumbergs; J Manavis
Journal:  J Comp Pathol       Date:  1999-05       Impact factor: 1.311

View more
  18 in total

1.  Focus issue on clostridial disease.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jesse M Hostetter
Journal:  J Vet Diagn Invest       Date:  2020-02-28       Impact factor: 1.279

2.  Outbreaks of Typhlocolitis Caused by Hypervirulent Group ST1 Clostridioides difficile in Highly Immunocompromised Strains of Mice.

Authors:  Kathleen G L Ma; Kvin Lertpiriyapong; Alessandra Piersigilli; Irina Dobtsis; Juliette R K Wipf; Eric R Littmann; Ingrid Leiner; Eric G Pamer; Rodolfo J Ricart Arbona; Neil S Lipman
Journal:  Comp Med       Date:  2020-05-13       Impact factor: 0.982

3.  Effect of Porcine Clostridium perfringens on Intestinal Barrier, Immunity, and Quantitative Analysis of Intestinal Bacterial Communities in Mice.

Authors:  Zipeng Jiang; Weifa Su; Chaoyue Wen; Wentao Li; Yu Zhang; Tao Gong; Shuai Du; Xinxia Wang; Zeqing Lu; Mingliang Jin; Yizhen Wang
Journal:  Front Vet Sci       Date:  2022-06-13

Review 4.  Bacterial and viral enterocolitis in horses: a review.

Authors:  Francisco A Uzal; Luis G Arroyo; Mauricio A Navarro; Diego E Gomez; Javier Asín; Eileen Henderson
Journal:  J Vet Diagn Invest       Date:  2021-11-11       Impact factor: 1.569

Review 5.  The Gastrointestinal Microbiota of the Common Marmoset (Callithrix jacchus).

Authors:  Alexander Sheh
Journal:  ILAR J       Date:  2020-12-31

Review 6.  The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.

Authors:  Mahmood Y Hachim; Noha M Elemam; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

7.  Identifying the Basis for VirS/VirR Two-Component Regulatory System Control of Clostridium perfringens Beta-Toxin Production.

Authors:  Iman Mehdizadeh Gohari; Jihong Li; Bruce A McClane
Journal:  J Bacteriol       Date:  2021-08-20       Impact factor: 3.490

8.  Comparative Genomics of Clostridium perfringens Reveals Patterns of Host-Associated Phylogenetic Clades and Virulence Factors.

Authors:  Renae R Geier; Thomas G Rehberger; Alexandra H Smith
Journal:  Front Microbiol       Date:  2021-06-09       Impact factor: 5.640

9.  Molecular Characterization of Clostridium perfringens Strains Isolated in Italy.

Authors:  Katia Forti; Laura Ferroni; Martina Pellegrini; Deborah Cruciani; Antonio De Giuseppe; Silvia Crotti; Paola Papa; Carmen Maresca; Giulio Severi; Maria Luisa Marenzoni; Monica Cagiola
Journal:  Toxins (Basel)       Date:  2020-10-08       Impact factor: 4.546

10.  Evidence That VirS Is a Receptor for the Signaling Peptide of the Clostridium perfringens Agr-like Quorum Sensing System.

Authors:  Jihong Li; Bruce A McClane
Journal:  mBio       Date:  2020-09-15       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.